COVID vaccine makers AstraZeneca have had another important drug approved that will help cancer patients in Scotland.
The pharmaceutical giants, whose Oxford-AstraZeneca jab is now being used to protect people from the killer coronavirus around the world, were this week given the green light for a medicine to treat the most common type of leukaemia.
5
Around 260 people are diagnosed with the incurable chronic lymphocytic leukaemia – CLL – every year and face gruelling chemotherapy treatment in hospital.
But now the Scottish Medicines Consortium has rubber stamped AstraZeneca’s acalabrutinib which comes in pill form that can be popped at home.
And Leukaemia sufferer John Greensmyth – a trustee at the CLL Support group – believes going without the monthly chemotherapy infusions will help improve the lives of patients.
5
The 63-year-old, who…
